Swiss National Bank
CABA icon

Swiss National Bank’s Cabaletta Bio CABA Stock Holding History

Swiss National Bank’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-66,500
Closed -$497K – 2470
2024
Q2 		$497K Buy
66,500
+7,300
+12% +$89.5K ﹤0.01% 2421
2024
Q1 		$1.01M Buy
59,200
+8,200
+16% +$176K ﹤0.01% 2218
2023
Q4 		$1.16M Sell
51,000
-10,100
-17% -$170K ﹤0.01% 2160
2023
Q3 		$930K Buy
+61,100
New +$835K ﹤0.01% 2282

Other funds holding CABA

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Swiss National Bank's CABA Position: Q3 2024 in Review

Swiss National Bank sold out of Cabaletta Bio (CABA) in Q3 2024, closing a stake of 66,500 shares — an estimated $497K sold.

Swiss National Bank first reported a position in CABA in Q3 2023 and held it in 4 quarters. The position peaked at $1.16M in Q4 2023. 120 funds tracked by Wall St. Rank hold CABA as of Q3 2024.

  • Swiss National Bank reported no remaining Cabaletta Bio position as of Q3 2024 after selling out during the quarter.
  • Swiss National Bank sold 66,500 Cabaletta Bio shares in Q3 2024, an estimated $497K.
  • Swiss National Bank first reported a position in Cabaletta Bio in Q3 2023 and held it in 4 quarters.
  • Swiss National Bank's Cabaletta Bio position peaked at $1.16M in Q4 2023.
  • 120 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2024.

Based on Swiss National Bank's 13F filing for Q3 2024, filed 7 Nov 2024.